ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Hutchinson Awarded $8 Million Grant For Pancreatic, Colorectal Cancer Studies

September 18, 1998

In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10

May 9, 1975

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

New Reagan Budget Or FY 1982 gives NCI $1.026 Billion

March 6, 1981

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983